Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R I Walker

Showing results (131-140 of 140) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 140 results.
Vaccine|January 1, 1995
Safety and immunogenicity of a prototype oral whole-cell killed Campylobacter vaccine administered with a mucosal adjuvant in non-human primatesS Baqar, A L Bourgeois, P J Schultheiss, et al.
The American Journal of Physiology|March 1, 1988
Cardiovascular performance with E. coli challenges in a canine model of human sepsisC Natanson, R L Danner, M P Fink, et al.
Advances in Shock Research|January 1, 1980
Protection of dogs from lethal consequences of endotoxemia with plasma or leukocyte transfusionsR I Walker, J E French, D A Walden, et al.
Clinical Chemistry|April 29, 1998
Automated fluorescent analysis procedure for enzymatic mutation detectionB J Del Tito, H E Poff, M A Novotny, et al.
Infection and Immunity|August 1, 1989
Trehalose dimycolate enhances resistance to infection in neutropenic animalsG S Madonna, G D Ledney, T B Elliott, et al.
Clinical and Vaccine Immunology : CVI|January 10, 2014
Development and preclinical evaluation of a trivalent, formalin-inactivated Shigella whole-cell vaccineR W Kaminski, M Wu, K R Turbyfill, et al.
The Journal of Clinical Investigation|January 1, 1989
Role of endotoxemia in cardiovascular dysfunction and mortality. Escherichia coli and Staphylococcus aureus challenges in a canine model of human septic shockC Natanson, R L Danner, R J Elin, et al.
Journal of Clinical Microbiology|April 1, 1981
Association of Aeromonas sobria with human infectionO P Daily, S W Joseph, J C Coolbaugh, et al.
Vaccine|August 13, 2005
Safety and immunogenicity of an oral, inactivated, whole-cell vaccine for Shigella sonnei: preclinical studies and a Phase I trialR McKenzie, R I Walker, G S Nabors, et al.
Zentralblatt Fur Bakteriologie : International Journal of Medical Microbiology|April 1, 1996
Problems and priorities for controlling opportunistic pathogens with new antimicrobial strategies; an overview of current literatureB A Araneo, J J Cebra, J Beuth, et al.
Pageof 14

Showing results (131-140 of 140) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 140 results.
Vaccine|January 1, 1995
Safety and immunogenicity of a prototype oral whole-cell killed Campylobacter vaccine administered with a mucosal adjuvant in non-human primatesS Baqar, A L Bourgeois, P J Schultheiss, et al.
The American Journal of Physiology|March 1, 1988
Cardiovascular performance with E. coli challenges in a canine model of human sepsisC Natanson, R L Danner, M P Fink, et al.
Advances in Shock Research|January 1, 1980
Protection of dogs from lethal consequences of endotoxemia with plasma or leukocyte transfusionsR I Walker, J E French, D A Walden, et al.
Clinical Chemistry|April 29, 1998
Automated fluorescent analysis procedure for enzymatic mutation detectionB J Del Tito, H E Poff, M A Novotny, et al.
Infection and Immunity|August 1, 1989
Trehalose dimycolate enhances resistance to infection in neutropenic animalsG S Madonna, G D Ledney, T B Elliott, et al.
Clinical and Vaccine Immunology : CVI|January 10, 2014
Development and preclinical evaluation of a trivalent, formalin-inactivated Shigella whole-cell vaccineR W Kaminski, M Wu, K R Turbyfill, et al.
The Journal of Clinical Investigation|January 1, 1989
Role of endotoxemia in cardiovascular dysfunction and mortality. Escherichia coli and Staphylococcus aureus challenges in a canine model of human septic shockC Natanson, R L Danner, R J Elin, et al.
Journal of Clinical Microbiology|April 1, 1981
Association of Aeromonas sobria with human infectionO P Daily, S W Joseph, J C Coolbaugh, et al.
Vaccine|August 13, 2005
Safety and immunogenicity of an oral, inactivated, whole-cell vaccine for Shigella sonnei: preclinical studies and a Phase I trialR McKenzie, R I Walker, G S Nabors, et al.
Zentralblatt Fur Bakteriologie : International Journal of Medical Microbiology|April 1, 1996
Problems and priorities for controlling opportunistic pathogens with new antimicrobial strategies; an overview of current literatureB A Araneo, J J Cebra, J Beuth, et al.
Pageof 14